Royalty Pharma plc (Nasdaq: RPRX) today announced a research and development (R&D) co-funding agreement with Johnson & Johnson for a total of $500 million in 2026 and 2027 to advance the development ...
Copenhagen, DK and Boston, MA, U.S. November 05, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of ...
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it has been selected ...
invoX Pharma Limited (“invoX”), a research-driven global biopharmaceutical company with an advancing pipeline of innovative products, and Insilico Medicine (“Insilico”), a leading and global clinical ...
Hosted on MSN
Govt floats EOI for doing major Research & Development in pharma medtech sector and drugs
New Delhi: The government has sought expressions of interest (EoI) for research & development (R&D) projects to develop novel technologies in medicine, including medical devices and drugs for ...
What are the top ten companies that academics go to when taking a research position in the private sector? There are a lot to choose from. The world of commercial research and development (R&D) spans ...
INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to ...
Market OverviewThe global Pharma Contract Commercialization Organization (CCO) market is steadily evolving and is projected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results